Cambridge Trust’s Affirm AFRM Stock Holding History

Cambridge Trust’s Portfolio AFRM Stock Details AFRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-68	Closed	-$3K	–	848
2022 Q1	$3K	Hold	68	–	–	﹤0.01%	844
2021 Q4	$7K	Buy	+68	New	+$8.98K	﹤0.01%	858

Other funds holding AFRM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cambridge Trust's AFRM Position: Q2 2022 in Review

Cambridge Trust sold out of Affirm (AFRM) in Q2 2022, closing a stake of 68 shares — an estimated $3K sold.

Cambridge Trust first reported a position in AFRM in Q4 2021 and held it in 2 quarters. The position peaked at $7K in Q4 2021. 347 funds tracked by Wall St. Rank hold AFRM as of Q2 2022.

Cambridge Trust reported no remaining Affirm position as of Q2 2022 after selling out during the quarter.
Cambridge Trust sold 68 Affirm shares in Q2 2022, an estimated $3K.
Cambridge Trust first reported a position in Affirm in Q4 2021 and held it in 2 quarters.
Cambridge Trust's Affirm position peaked at $7K in Q4 2021.
347 funds tracked by Wall St. Rank held Affirm as of Q2 2022.

Based on Cambridge Trust's 13F filing for Q2 2022, filed 16 Aug 2022.